Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Q-linea AB ( (SE:QLINEA) ) has provided an update.
Q-linea AB announced a correction to its previously released timetable for a reverse share split, clarifying that the last trading day before the split is 11 July 2025, not 13 July 2025. The reverse share split will reduce the total number of shares significantly and will automatically adjust shareholders’ holdings via Euroclear Sweden AB, with no action required from shareholders. This strategic move is expected to streamline the company’s share structure, potentially enhancing market perception and shareholder value.
More about Q-linea AB
Q-linea is a company specializing in rapid antimicrobial susceptibility testing systems, notably the ASTar® system, which aids hospitals in quickly determining optimal antimicrobial therapies for patients with bloodstream infections and sepsis. Headquartered in Uppsala, Sweden, Q-linea operates globally with regional offices in Italy and the USA, and its products are CE-IVD marked and FDA 510(k) cleared.
Average Trading Volume: 30,007,255
Current Market Cap: SEK412.1M
See more data about QLINEA stock on TipRanks’ Stock Analysis page.